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1. Abstract 
The implementation of in vitro results to in vivo applications has limitations due to 
conventional two-dimensional (2D) in vitro conditions lacking the ability to create a 
physiologically representative model. This study investigated a three-dimensional (3D) cell 
culture technique to model lung tumors in vitro.  A 3D lung cancer model was created by 
applying collagen (a semi-non-adhesive material) to a transwell, which allowed for nutrient 
transfer through the collagen. Two lung cancer cells lines (H358, a bronchioalveolar carcinoma 
and A549, a lung adenocarcinoma) were seeded on top of the collagen. The non-adhesive 
collagen allowed the cells to preferentially attach to one another rather than to the surface, thus 
creating multicellular spheroids (MCS). To better mimic the environment for lung cancer 
specifically, an air-interface culture (AIC) as opposed to the commonly used liquid-covered 
culture (LCC) was created. For AIC conditions, the cell media on the apical side of the Transwell 
was removed and the basolateral side of the well was filled with cell media to allow for effective 
nutrient transport to the cells while also exposing the cells to air. A comparison of 2D and 3D 
cell behavior and viability was completed using paclitaxel and aerosol particles containing 
paclitaxel as a representative model for drug delivery.  
As evidenced with brightfield and fluorescent microscopy imaging, the AIC model 
proved to yield viable MCS at sizes similar to MCS formed in LCC conditions (100 to 200μm in 
diameter). With the optimized 3D model, LCC cells were exposed to paclitaxel in media. In 
another drug delivery method, paclitaxel-loaded dry powder aerosol particles were delivered to 
AIC cells through direct application with an insufflator. This alternative delivery method using 
direct delivery of dry powder particles was be used as the drug application method on AIC since 
paclitaxel cannot be delivered through media as in LCC conditions. The nanoparticles containing 
paclitaxel are comprised of a PEGylated phospholipid excipient mixture which encapsulates the 
drug. Using viability analysis, it was shown that the applications of paclitaxel in LCC conditions 
show variance in efficacy when comparing 2D and 3D culture conditions (where the IC50 values 
for paclitaxel were higher for 3D compared to 2D).  Transepithelial electrical resistance (TEER) 
 
 
 
 
across Calu-3 (another lung adenocarcinoma cell line) monolayers was evaluated before and 
after particle delivery to illustrate that the particle application does not affect the permeability of 
the cells, which indicated that this form of drug therapy will not affect the permeability of lung 
tissue. Overall, a much more representative in vitro model has been developed that is expected to 
be an improved predictor of efficacy of alternative drug delivery methods such as direct 
pulmonary delivery for lung cancer, which could lead to more efficient drug therapies for lung 
cancer patients. 
 
2. Introduction 
2.1 The Importance of Lung Cancer Research 
 People in the United States die from lung cancer more than any other cancer diagnosis 
[1]. It is a prominent cause of death and is therefore a large focus in the research community 
today.  There are many methods of treatment in use including chemotherapy, radiation, surgery, 
photodynamic therapy, or a combination of these [2]. In vitro models are a major factor in 
analyzing the effectiveness of treatment of drug chemotherapeutics. In lung cancer specifically, 
there are many characteristic elements of a tumor and tumor site that require an in vitro model to 
be altered and manipulated in order to make the model as physiologically representative as 
possible. 
 
2.1 Purpose, Project Objectives, and Hypothesis 
 The purpose of this project was to develop an in vitro lung tumor model that could mimic 
in vivo tumor shape, behavior, and environment more closely and effectively and observe the 
effects of this model on chemotherapeutic drug studies. In order to do this, many aspects of the 
cell culturing methods to form a tumor model had to be altered. Specifically, a model that was 
three-dimensional, possessed a surrounding environment like an in vivo tumor, and could also be 
exposed to air (as cancer cells are in the lung) and continue to yield proliferating cells needed to 
be established. Therefore, the first objective of the project was to develop and optimize the 
 
 
 
 
culturing conditions of three-dimensional lung multicellular spheroids in air interface and liquid 
covered culture conditions, ensuring proper spheroid development and viability. The next step 
was to evaluate the difference in cellular response of two-dimensional (2D) and three-
dimensional (3D) cultured cells to the chemotherapeutic drug paclitaxel delivered under liquid 
covered culture conditions. Furthermore, in considering that lung cancer cells uniquely grow in 
the presence of air, the final objective was to evaluate the difference in cellular response of 2D 
and 3D cultured cells to paclitaxel-loaded dry powder aerosol particles under air interface culture 
conditions.  
 The two different culturing methods of air interface and liquid covered culture were 
expected to yield similarly sized multicellular spheroids with equally viable cells. Once each of 
these models was established, the delivery of paclitaxel to the 3D cultured cancer cells under 
liquid covered culture conditions was predicted to return results that show that there was less of a 
response, in the 3D model to the drug than in the 2D model. Similarly, in the delivery of 
paclitaxel-loaded dry powder aerosol particles to the 3D model under air interface culture 
conditions, it was conjectured that the results would show less of a response in the 3D model 
than in the 2D model as well.  
 There are many benefits of this study and gathering this information. Determining the 
difference between 3D and 2D would allow more predictable transitions from initial in vitro 
studies to in vivo studies. In gathering knowledge about cancer drug efficacy and potency with 
this specific tumor model that considers pulmonary conditions, which is more physiologically 
representative for lung tumors, it will reveal valuable information about the potential of direct 
pulmonary chemotherapeutic delivery. Ultimately, the possibility of a more effective and 
efficient application of drug therapy will be an option for lung cancer patients. 
 
2.2 Multicellular Spheroids and Development 
 The typical way to form a 3-dimensional tumor model is the formation of multicellular 
spheroids. Multicellular spheroids (MCS) are a three-dimensional configuration of cells. They 
 
 
 
 
are largely beneficial when utilized as a 3D tumor model because they recreate a tumor and its 
surrounding environment quite closely. MCS form as cells grow and attach to each other. When 
they aggregate the integrin of the cells begin to interact with each other forming cadherin-
cadherin bonds. The more bonds formed, the more compact the cells become, forming a 3D 
spheroid shape. The integrins also react to form an extracellular matrix (ECM) consisting of 
fibrous proteins and proteoglycans that are made in cell and secreted by exocytosis. The ECM 
provides structure for the cell formation, regulates the cell to cell interactions, and assists in cell 
hydration.  The innermost layer of the spheroid consists of a necrotic core, surrounded by a layer 
of quiescent cells, with an outermost layer of proliferating cells [3]. The specific advantages of 
these characteristics of MCS are discussed in the next section. In general, all of these 
characteristics create a model that closely mimics that of a tumor model, allowing a smoother 
transition from in vitro to in vivo drug treatment studies and an ability to better predict in vivo 
results. 
 There are many methods of creating multicellular spheroids. Some common methods 
include liquid overlay, hanging drop, micromolding, spinner flask, rotary culture, and 
centrifugation. In liquid overlay, well plates are coated with a non-adhesive, partially hydrophilic 
material to create a surface on which the cells, once seeded, are more often inclined to attach to 
each other than to the surface. For the hanging drop method, cells in solution are seeded in 
multiple drops on the lid of a Petri dish or well plate. When the lid is turned over on top of the 
plate, the droplet does not fall due to adhesion, while gravity gathers the cells at the bottom of 
the droplet. Micromolding cells involves seeding the cells in solution in a plate that contains a 
series of very small rounded “molds” so that cells can gather at the bottom of the mold. In 
spinner flask culture, cells in excess solution are placed in a flask and constantly spun at certain 
speeds in order to keep the cells suspended in solution. Having nothing else on which to attach, 
the cells begin to attach to each other. In a rotary culture, cells are seeded in media into a 
rounded wheel-like container that constantly turns so that the cells gathered at the bottom of the 
container never have enough time to attach to the surface of the container. Therefore, again, with 
 
 
 
 
nothing else to attach to and gathered together, they begin to attach and interact with each other. 
Finally, in centrifugation, cells are placed in media in a centrifuge tube and spun so that the cells 
pack into the bottom of the tube and begin to interact. [3] The method used in this particular 
project was the primarily mentioned liquid overlay. This method tends to work contingent upon 
the response of the cell line to this form of cell culture [4]. This is also one of the only methods 
that allows the use of an air interface conditions as a variable characteristic, which is discussed 
later. Overall, the formation of an MCS is the ideal 3D model and its desired characteristics for 
this project. 
 
2.3 Three-Dimensional and Two-Dimensional Models 
 Drug testing is most often performed on cancer cell lines that are cultured in the 
conventional two-dimensional (2D) method. This form of cell culturing can be compared to the 
more complex but at many times more beneficial three-dimensional (3D) method. The benefits 
of a 3D model are numerous when considering that the goal of the model is to recreate tumor-
like behavior and environment. The many characteristics of MCS mimic real in vivo tumors. The 
MCS contain necrotic cores, allowing many of the cells to be fairly “protected” by the outermost 
layer of cells. Since dug therapeutics will often be designed to attack proliferating cancer cells, a 
frequent occurrence is that the drug will successfully cause apoptosis in the outermost layer of a 
tumor, however, the necrotic core and quiescent cells are left alone. Once the outermost layer of 
cells die and break away, the quiescent cells begin to receive nutrients and proliferate [5]. This is 
an important characteristic to recreate so that certain drugs are not incorrectly labeled with a high 
efficacy when they are only effective on an outer layer of proliferating cancer cells. This 
characteristic may also be recreated with a 3D MCS model again because of its ability to create 
compact MCS that are separated from media by each other, an ECM, as well as other surfactant 
proteins secreted by the cells [7]. Furthermore, the ECM present provides structure and assists in 
cell hydration throughout the MCS with lessened exposure to the nutrients in media [5]. Directly 
following, this avascular model allows the buildup of metabolism including carbonic and lactic 
 
 
 
 
acid causing a lower pH in and around the MCS, which also mimics in vivo tumors [14]. These 
aspects that mimic in vivo tumors are important when the goal of the model is to closely predict 
cellular response to certain anti-cancer drugs. 
  These advantages become noticeably more meaningful when a comparison to a 2D model 
is observed. The 2D method simply involves seeding cells grown in a flask with cell media for 
nutrients into well plates with a rough plastic surface on the bottom, so that the cells are able to 
attach to and grow on this uneven surface. This method of cell culturing has advantages and 
disadvantages when utilizing the cells for testing cancer drug efficacy and potency. This model 
allows quick and easy tests that can be done in a 96-well plate. Since many more trials can be 
done at once, it is consequently less expensive to do these tests on a large scale. However, the 
cells seeded in a 2D configuration will usually grow in the form of a monolayer of cells. This 
implies that, since the cells attach to the rough plastic surface of the well, they do not attach to or 
react with each other. Without cell to cell interactions, the cells are not induced to produce 
proteins or any surfactant. This results in a lack of an extracellular matrix, in turn resulting in no 
structure or support or extra hydration that an ECM brings. The fact that the cells do not attach to 
one another and build up means a lack of protection from other cells; each cell is just as exposed 
to its surroundings (including drug exposure) as any other cell. For this reason, a 2D model often 
displays results with a more sensitive response to a drug than what ends up being the case in 
vivo. [8] 
 
2.4 Air Interface Culture and Liquid Covered Culture 
 The method of using liquid overlay to create MCS can be varied in another way. Liquid 
covered culture (LCC) is the condition of liquid overlay in which the cells are seeded onto a non-
adhesive surface by applying the cells in media on top of the surface. The media that brings 
nutrients remains on top of the surface and the cells to keep nutrients available to the cells.  Air 
interface culture (AIC) differs in that once the cells are no longer suspended in the media and 
have attached to the surface and one another, the media is removed so that the cells may be 
 
 
 
 
exposed to air as well. In order to retrieve nutrients under these conditions, the non-adhesive 
material and the cells are often seeded in transwells that sit in the wells of a well plate. Media 
may be applied to the well itself, and the cells are able to retrieve nutrients as the media passes 
through the permeable bottom of the transwell [9] and also through the non-adhesive material to 
the cells. An asset of this type of culture is that the surfactant that is produced by lung cancer 
cells can often be washed away in cell media when LCC conditions are utilized. In AIC 
conditions, this surfactant would be able to remain intact, creating yet another aspect of an in 
vivo lung tumor to be represented in the MCS model [10]. In addition, AIC conditions allow the 
obvious but unique aspect of lung tumors to be mimicked; these cancer cells are exposed to air in 
the lungs.  
 
2.5 Cell Lines 
 There were three cell lines used for this project. H358 cells are Bronchioalveolar 
carcinoma cells, which is a type II alveolar non-small cell lung cancer. A549 are Lung 
adenocarcinoma, which is also a type II alveolar cancer cell. [4] Both of these cell lines are 
known as type II alveolar cells, also known as pneumocytes, which are known to secrete a 
characteristic mucous layer when interacting with each other, as well as surfactant proteins such 
as A(SP-A), a pulmonary surfactant. A(SP-A) counteracts inhibitory proteins during lung injury. 
It also reduces surface tension among the cells, acting as a host site for particles and allowing for 
an attractive landing site for these particles. Harmful particles are bound by this protein in order 
to protect the lung [6]. These cell lines have proven to be good candidates for creating MCS 
through the use of the liquid overlay method [4]. The last cell line, Calu-3, are also a lung 
adenocarcinoma. This cell line forms very tightly-formed monolayers that allows for high levels 
of resistance, which was used ideally for TEER analysis studies [13]. 
  
2.6 Paclitaxel and DPPC:PTX  Particles  
 
 
 
 
Paclitaxel (PTX), also known as Taxol or Taxoprexin, is a largely popular, new 
upcoming anti-cancer drug (structure seen in Figure 1). It is one of the top five cancer drugs in 
research in the past few years. This drug was extracted and developed from the Pacific Yew 
Tree, a rare plant, which has led to its synthesis in the laboratory to be researched. It has proven 
to be a very effective drug, but it is nearly insoluble in water, and therefore must be dissolved in 
Dimethyl Sulfoxide (DMSO) in order to be applicable in solution. Paclitaxel functions as a 
mitotic inhibitor, stabilizing microtubules in cells to prevent cell division. Also, the apoptotic 
activity of this drug is able to influence penetrability of the outer layer of cells, allowing the drug 
to penetrate solid tumors depending on the tumor’s cellularity and density. For these reasons, 
PTX is an ideal drug to use for this project. [11] 
 For a direct pulmonary delivery model, aerosol nanocomposite microparticles loaded 
with paclitaxel were made via spray drying. The components of the lipospheres formed are 
Dipalmitoyl phosphatidylcholine (DPPC) and the drug paclitaxel (PTX). These components 
molecular structures can be seen in Figure 1. 
 (1)  
 
(2)  
Figure 1. Molecular structures of: (1) DPPC, (2) Paclitaxel. 
 
 
 
 
 
DPPC is a major constituent in lung surfactant (about 80% DPPC), so it is safe in the 
lungs upon degradation. This also assists in decreasing toxicity because no additional agents are 
needed for solubility since this component is already largely soluble. When spray dried, the 
DPPC forms a spherical shape called a liposphere. These particles can be loaded with many 
different therapeutic agents, and for this project PTX was used. These components combine to 
form particles approximately 400-1500nm in diameter and can penetrate into the deep lung 
regions. The location of particle deposition can also be tuned by varying the particle size slightly. 
These dry powder particles can be applied to cells cultured in AIC conditions in vitro via an 
insufflator (Figure 2), mimicking a direct pulmonary delivery through a dry powder inhaler. 
These particles would then make a path through the airway interstitial tissue to the epithelial 
lining, and finally really the tumor or local blood supply at which it would release the therapeutic 
drug. [12] 
 
 
Figure 2. Schematic of insufflator. 
 
2.7 TEER 
 Transepithelial Electrical Resistance (TEER) is a measurement of the electrical resistance 
across a cell monolayer. This measurement can be used to analyze the packing density and 
 
 
 
 
permeability of the cells in a monolayer. It is often utilized to ensure that packing density does 
not decrease with the addition of any treatments to the cells being used in experimentation. The 
purpose of this analysis for this project is to ensure that the permeability of Calu-3 cells grown 
under AIC and LCC conditions are not significantly different, as well as to ensure that the 
delivery of any chemotherapeutic particles to the cells would not significantly increase the cells’ 
monolayer permeability. If this were to occur, the cell tissue in the lung would become 
compromised and allow fluid to permeate the tissue. TEER across cells in AIC and LCC 
conditions has been established to have statistically equal resistance levels [13]. For this project, 
equal resistance levels are desired for cells grown under AIC conditions without any nanoparticle 
exposure, cells exposed to blank (DPPC only) aerosolized lipospheres, and cells exposed to 
drug-loaded (DPPC:PTX) lipospheres. This analysis involves measuring the resistance of the 
cells by growing a cell monolayer under both LCC and AIC conditions, exposing the AIC cells 
to nanoparticles through direct delivery, and placing the monolayer between two electrodes in 
order to gather the resistance measurement across the monolayer before and after exposure. 
Although this study involves a 3D model for drug delivery, in order to obtain a resistance 
measurement the cells must be confluent, otherwise the resistance would not be uniform between 
the electrodes. Also, the Calu-3 monolayer is meant to represent healthy lung tissue in this study 
because it has many characteristics of lung cells despite the fact that it is technically a lung 
cancer cell line. For these reasons, the cells were grown in a 2D model [13].  
 
3. Materials and Methods 
3.1 Cell Seeding 
 In order to have a steady supply of cells to seed and plate into wells for each experiment, 
each cell line was broken out into flasks and grown with phenol-red free cell media until they 
were ready to be seeded. This media used throughout the project was made my mixing 445mL 
Dulbecco's Modified Eagle Medium (DMEM), 50mL Fetal Bovine Serum (FBS), 292mg L-
Glutamine, and five milliliters Sodium Pyruvate, and vacuum-filtering it for sterilization. This 
 
 
 
 
media is ideal for this experiment in that it is a clear, pale yellow color and is transparent for the 
viewing/imaging of cells. The cells were allowed to grow in an incubator at 37 °C until about 
60% confluence and were split. At this time, the cells were washed with 2mL of trypsin, a 
digestive enzyme that enables the cells to detach from the rough plastic surface of the flask. 
Another 3mL of trypsin was added to the flask and the flask was allowed to incubate for 15-20 
minutes to allow full detachment of cells. When all cells were detached, 7mL of DMEM media 
was added to the flask for a total of a 10mL cell solution. Twenty microliters of this solution was 
placed into the Cell-O-Meter (cell counting instrumentation/software) in the culture lab. This 
software provided cell density information, and allowed a dilution to the preferred cell seeding 
density to be calculated (varying according to each experiment and cell line). The cell solution 
was then diluted with media to this preferred density and pipetted into the well plates for each 
experiment.   
 
3.2 Two-Dimensional Study with Paclitaxel 
 Both H358 and A549 cell lines were diluted to 75,000 cells/mL and 30,000 cells/mL, 
respectively, and seeded in a 96-well plate at 200μL/well with half of the plate seeded with H358 
and the other half A549. These seeding densities were chosen based on knowledge of each cell 
line’s doubling growth rate. The cells were allowed to grow for 48 hours and then paclitaxel was 
added in eight different concentrations (varying from 5μM to .0001μM) across the plate. 
Paclitaxel, as previously mentioned, needed to be dissolved in DMSO. Therefore, a stock 
solution was made of 5000μM PTX in DMSO (or 4.27mg PTX/mL DMSO).  The paclitaxel 
being fully dissolved, the solution was then diluted with DMEM media to a nontoxic amount of 
DMSO (.10% vol.). A DMSO/media control as well as a media only control was also used. The 
PTX was then applied to the cells in the 96-well plate with half the cells seeded with A549 and 
another half seeded with H358, each column containing a different concentration of PTX or a 
control. With this format, cell viability would be able to be calculated with the proper controls. 
 
 
Amount of rat tail collagen to add:             
  (                            ) (                            )
(                              )
 
Amount of 1N NaOH to add:    (                         )  (       
  
) 
Amount of dH2O to add:  Volume initial collagen solution – Amount of PBS to add – 
Amount of rat tail collagen to add – Amount of NaOH to add 
All ingredients were then combined, the rat tail collagen was slowly added last, and the solution 
mixed well. The final collagen solution was then prepared, which consisted of the initial collagen 
solution at 70% of the volume of the volume of final collagen solution needed, 20% DMEM 
media, and 10% FBS. These components were again combined, slowly adding the collagen 
solution last, and mixed well. The collagen was added to the wells at 900μL/well and allowed to 
incubate at 37 °C for 20-30 minutes for solidification. This procedure was followed for the 
preparation of the non-adhesive surface on which the cells would be seeded. For 3D liquid 
covered culture conditions only, which were to be compared to the 2D study, collagen was plated 
 
 
 
 
in two 24-well plates. H358 and A549 cells were seeded in two separate well plates with seeding 
densities of 40,000cells/mL and 15,000cells/mL, respectively, on top of the collagen after it was 
solidified. The schematic of the well can be seen in Figure 3.  
 
 
Figure 3. Schematic of LCC well for 3D culture. 
 
MCS were allowed to grow for about 9 days, or until they reached an average diameter of about 
50-100μm, and then paclitaxel was delivered to the cells in five different concentrations and left 
exposed to the drug for 72 hours. The paclitaxel was dissolved in DMSO in the same way as the 
2D study and diluted the same way. Five different concentrations (from 1μM to .0001μM) were 
delivered to the cells (4 wells each concentration), and the last four wells acted as controls and 
were exposed to only a DMSO/media solution. Only one control containing DMSO and media 
was used because the differences in the 2D study between the DMSO/media control and the 
media only control were insignificant. 
 
3.4 Air Interface and Liquid Covered Culturing 
 The ability to optimize an air interface cultured MCS was an important part of this 
project. In order to compare the success of this type of culture to the liquid covered culture, cells 
were seeded very similarly to the procedure described in section 3.2, with some slight alterations. 
In this part of the study, collagen was plated in transwells that fit into 12-well plates. Six 
transwells were seeded with the A549 cell line and six were seeded with the H358 cell line at a 
seeding density of 15,000cells/mL and 40,000cells/mL, respectively. 500μL of cell solution was 
 
 
 
 
added to the apical side of the transwell, and 1,500μL of DMEM media was added to the 
basolateral side of the transwell. In order to create AIC conditions, after 24 hours, the cells were 
attached to the collagen and each other, and the media was removed from the apical side of three 
of the transwells containing A549 cells and three of the transwells containing H358 cells. This 
layout can be seen in Figure 4. The media continued to permeate through the bottom of the 
transwell as well as through the collagen in order for the cells to continue to receive nutrients. 
The growth of the MCS were compared between  the wells that continued to receive nutrients 
from the media on the apical side of the well (LCC) and the wells that were exposed to air and 
received nutrients from the basolateral side of the well (AIC). 
 
 
Figure 4. AIC and LCC conditions schematic. 
 
In addition to seeding the A549 cell line in 3D on top of collagen, they were also seeded with the 
same procedure as described above, but without the addition of collagen. This allowed a 
monolayer of A549 cells to grow in both AIC and LCC conditions. This experiment was done in 
order to perform another type of analysis to ensure that the permeability of air interface cultured 
cells exposed to the drug-loaded nanoparticles is not affected, indicating that the lung tissue in 
vivo would not be compromised when the drug-loaded nanoparticles were delivered to a patient’s 
lungs.  
 
3.5 Live/Dead Assay Preparation 
 
 
 
 
 In analyzing the viability of cells after drug delivery, a live/dead fluorescent assay was 
prepared. This procedure started with the removal of all media from the wells. Then each well 
was washed with 500μL of sterile PBS. The assay was then prepared in a centrifuge tube of 
necessary size with 4,970μL PBS, 10μL Calcein AM (CAM), and 20μL Ethidium Homodimer-1 
(Eth-D). These ingredients were added in multiples of these amounts if more solution was 
needed. This solution was added to each well plate and left to incubate at 37 °C for 20-30 
minutes. CAM and Eth-D are fluorescent materials. This assay allows analysis of the amount of 
live and dead cells. CAM is able to permeate through a cell membrane and reacts with live cells’ 
enzymes to become entrapped inside the cell where it fluoresces. Eth-D is only able enter a cell 
membrane and fluoresce if the cell is dead and has a compromised membrane. This assay could 
be analyzed with the BioTek® Gen 5 2.00 Plate Reader by reading the amount of fluorescence of 
each material (CAM and Eth-D) as well as imaged with fluorescent microscopy to view viable 
and dead MCS.  
 
3.6 Resazurin Assay Preparation  
 Another fluorescent assay was used in analyzing the viability of cells after drug delivery 
called Resazurin. For this analysis, 50mL (or 10% volume) of Resazurin was simply added to the 
wells containing the MCS after 72 hours of exposure to PTX. The assay was allowed to incubate 
at 37 °C for 3 hours. Then 100μL from each well was transferred to a well in a 96-well plate so 
that the fluorescence of each well could be read by the plate reader. Resazurin becomes 
fluorescent when it reacts with the substances in the cell that contribute to mitochondrial activity. 
These substances are only produced when a cell is alive; therefore, the amount of fluorescence of 
Resazurin is directly proportional to the amount of live cells or the amount of cell viability. 
 
3.7 TEER Analysis 
 During TEER analysis, the electrical resistance across the Calu-3 cell monolayer—this 
cell line used due to its inclination to form a tightly packed monolayer—is measured using an 
 
 
 
 
electrode set on either side of the monolayer and measuring voltage resulting from a set current 
flow from one end to the other. The resistance is then calculated within the instrumentation. A 
description of the process of measuring the TEER across the cell monolayer using World 
Precision Instruments Epithelial Voltohmeter (Evom2) can be seen in Figure 5.  
 
 
 
 
 
 
 
 
Figure 5. Schematic of TEER analysis. Each side of the electrode is placed on either side of 
the cell monolayer seeded in the transwell. This electrode is connected to the Epithelial 
Voltohmeter, which displays the resistance (Ω). 
 
Once an equal resistance level is found for both LCC and AIC, blank lipospheres and PTX-
loaded lipospheres were exposed to AIC wells, and TEER was measured again in each well after 
24 hours. 
 
4. Results and Discussion 
4.1 MCS Development and Growth 
 In order to fulfill the first objective of the project, a 3D model cultured in both AIC and 
LCC was optimized. The growth of the two cell lines was monitored using brightfield 
microscopy. On the last day, a Live/Dead Assay was performed so that the amount of live cells 
could be viewed using fluorescent microscopy. A summary of these images can be seen in Figure 
6. 
 
 
 
 
 (i) 
 
 (ii) 
 
Figure 6. 3D spheroid formation brightfield images and final day Live/Dead images (with 
respect to time): (i) H358 and (ii) A549 where A through E are LCC conditions, F through 
J are AIC conditions. Images A and F, B and G, C and H, D and I, and E and J correspond 
to days 1, 4, 6, 8 and 9, respectively. Throughout the growth period the MCS grow to sizes 
varying from 50-250 μm. On the final day, Live/Dead imaging shows fully viable MCS. 
(Scale bar: 200μm) 
 
 The development of the MCS proved to be quite successful. The Live/Dead images on 
the final day displayed very few dead cells, which provided a good control when compared to 
MCS exposed to drug. Depending on the passage number of the cells when they were seeded, the 
cells sometimes grew and formed spheroids faster. The A549 cells did form fairly large MCS by 
day 9 at around 200-400μm, whereas the H358, which have a longer doubling time in general, 
 
 
 
 
formed MCS at around 100-250μm in the same amount of time. The average diameters of the 
MCS were measured using Nikon imaging software. A graph showing the actual diameter 
growth is displayed in Figure 7. Both cell lines proved to form viable MCS of reasonable size.  
 
 
 
Figure 7. Spheroid diameter/growth curves. Both A549 and H358 cell lines show similar 
diameter growth patterns in both LCC and AIC conditions. (Ave +/- SE, n=25). 
 
Although the A549 formed MCS faster, both cell lines showed a similar, significant, and steady 
increase in diameter over the elapsed time. This data confirmed that a successful 3D model had 
been reached in both AIC and LCC conditions.  
 
4.2 Comparison of 2D and 3D models in LCC conditions with Exposure to PTX 
The differences in response to drug delivery between a 2D model and the developed 3D 
model from this project were hypothesized to be significant.  The responses were analyzed using 
viability curves of the cells when exposed PTX and IC50 values from these dose response 
 
 
 
 
curves. IC50 values are defined as the concentration of an inhibitory drug at which the biological 
system and functions of the cells are inhibited by half. This value allows the effectiveness of a 
drug to be compared analytically in a quantitative way. The viability of the cells when exposed 
to multiple concentrations was measured using Live/Dead and Resazurin assays as described in 
the methods and materials section. A BioTek® Gen 5 2.00 plate reader examined and measured 
fluorescence given off by each well. In the Live/Dead assay, the level of Calcein AM 
fluorescence was an indication of viable the cells, while the level of Ethidium Homodimer-1 
fluorescence indicated the presence of dead cells. The percent viability was calculated using the 
two fluorescent measurements gathered by the plate reader, and comparing them to the control 
well’s fluorescence. The calculation for viability analysis used these calculations: 
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The average percent viability of the wells for each concentration was then found and used as the 
final data. Similarly, in a Resazurin assay, the more fluorescent the well was the more alive and 
viable the cells were. Percent viability was calculated using a very simple calculation: 
 
             
                                               
                                    
      
 
Again the average percent viability of the wells for each concentration was used as the final data. 
After calculating the viability at the multiple concentrations of PTX delivered, the data was 
 
 
 
 
combined to form a viability curve that displays the cell viability as a response to dose 
concentrations. The responses of the cells in the 2D model compared to the responses of the 3D 
model can be compared in Figure 8. 
 
 
 
Figure 8. Comparison between 2D and 3D model viability curves of A549 and H358 cell 
lines for: (A) 2D model and (B) 3D model.  (Ave +/- SE, 2D n=4, 3D n=3). 
 
Figure 8 illustrates that a transition from a 2D model to a 3D model can cause varying amounts 
of differences in dose response in differing cell lines. Overall both cell lines show less response 
to the drug paclitaxel in the 3D model than in the 2D model. This is to be expected since the 3D 
model allows many more characteristics of an in vivo tumor including more protection for cells 
in an MCS, as well as more stability and structure. These differences in response can be seen 
more quantitatively in the IC50 values in Table 1. 
 
 
 
 
 
 
 
 
 
Table 1. IC50 values for 2D and 3D model under LCC conditions. 
 
Cells Culture Condition PTX (μM) 
H358 2D 0.0152 ± 0.0039 
A549 2D 0.0046 ± 0.0018 
H358 3D 0.0836 ± 0.0159 
A549 3D 0.3335 ± 0.1258 
 
The IC50 values undeniably show that a larger concentration of PTX is needed to get the same 
cellular response to the drug in the 3D model.    
Beyond the viability of the cells, the growth of the MCS was also observed to see the 
affects of the drug on the actual growth of the MCS model. Images of the MCS were taken using 
brightfield and final day Live/Dead fluorescent microscopy. The Live/Dead images can be seen 
for both cell lines in Figure 9. 
 
 
Figure 9. Final day Live/Dead images of 3D cells exposed to PTX under LCC conditions 
where A through F are H358 cells and G through L are A549 cells. A and G, B and H, C 
and I, D and J, E and K, and F and L correspond to 0, 0.0001, 0.001, 0.01, 0.1, and 1 μM 
PTX respectively. (Scale bar: 200μm) 
 
The images show that the higher concentrations of paclitaxel clearly began to break up the MCS 
as they were inhibited. The termination of growth of the MCS and further breaking down of the 
 
 
 
 
MCS is evidenced by measuring the average diameter of the MCS throughout the drug delivery 
process. Figure 10 illustrates the MCS growth of the two cell lines when exposed to paclitaxel. 
 
 
        
Figure 10. MCS growth curves when exposed to PTX with respect to time where: (A) H358 
and (B) A549. (Ave +/- SE,  n=25). 
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 The TEER levels across a Calu-3 cell monolayer under LCC and AIC conditions were 
slightly different, but most of these results can be contributed to the fact that LCC conditions 
provide more nutrients to the monolayer after it is formed because the cells are exposed to media 
from the top and bottom of the monolayer. In AIC conditions, the cells on top of the monolayer 
cease to receive as much nutrient exposure. Then the comparison of TEER levels was made 
between control AIC monolayers and AIC monolayers exposed to blank DPPC lipospheres. The 
progression of TEER over time as the monolayers form and are exposed to lipospheres can be 
seen in Figure 11. 
 
 
Figure 11. TEER analysis for Calu-3 cell line with exposure to DPPC lipospheres. The wells 
with and without exposure to the lipospheres have statistically insignificant differences in 
TEER readings. (Ave +/- SD, n=3).  
 
As a monolayer formed, the resistance was insignificant until about day 22 when the monolayer fully 
covered the Transwell surface. The higher amount of error on that day was due to the fact that some wells 
 
 
 
 
had formed a full monolayer while others were still in the process of forming one. After all wells formed 
the monolayer, the cells continue to grow on top of each other, and the topmost cells do not receive 
nutrients from media in the AIC, resulting in slight cell death. This occurrence provides an explanation 
for the more significant decrease in TEER for AIC monolayers. When the DPPC lipospheres were 
exposed on day 24, however, the TEER remains statistically consistent with the control AIC wells even 
after 24 hours. This provides evidence that the exposure to lipospheres does not decrease cell packing 
density or increase monolayer permeability. 
 
4.4 Liposphere Application to 3D AIC 
 As a preliminary study, A549 and H358 spheroids were exposed to lipospheres of only two 
different amounts of PTX loaded onto the lipospheres. This study was to gauge where the concentration 
gradient will need to be for the dry powder lipospheres in order to get viability curves and IC50 values 
comparable to the 3D LCC study. The results of the preliminary study can be seen in Figure 12. 
 
 
Figure 12. Viability analysis on A549 and H358 spheroids after exposure to 0.1% and 1.0% (of the 
total liposphere weight) PTX-loaded lipospheres.  
 
 
 
 
 
 The preliminary study already suggests that the A549 cell line is much more resistant to this form 
of drug delivery. This confirms the hypothesis that A549 cells have more protection in an AIC 
environment because they secrete significantly more protective surfactants that form a mucosal layer. 
This aspect of their characterization would not be represented in the 3D LCC model. This study serves as 
a starting point for more viability analysis in 3D AIC studies with liposphere application. 
 
5. Conclusions 
 In recreating a closely physiologically representative model of an in vivo lung tumor, a 
plausible model is developed in seeding lung cancer cells on collagen in air interface culture 
conditions. This model yields viable multicellular spheroids at optimal sizes from about 100-
400μm in diameter depending upon the length of time they are allowed to grow. This model 
being more similar to an in vivo tumor in many ways, it better predicts the affects of a drug on a 
tumor in an in vivo study. In addition, a 3D MCS model in general creates a tumor-like 
environment and offers protection to the spheroids, resulting in a greater resistance to inhibition 
by inhibitory anti-cancer drugs like paclitaxel than a more sensitive 2D model would suggest. 
Furthermore, when using a 2D model, one could assume that when transferring the results to an 
in vivo study the cells exposed to the drug will show a different response and most likely be less 
sensitive to the same dosage. If a 3D model were to be used, the in vitro results would transfer 
much more smoothly and exhibit much more similar results to in vivo. This may lead to less 
extensive research needed in vivo, and a quicker transition of a chemotherapeutic drug into 
clinical trials. The implications that this more useful 3D model may result in less in vivo studies 
also assists in ethical as well as monetary issues with in vivo experimentation, considering the 
moral issues and expenses of animal testing. The differences in drug response which this 3D 
model denotes require acknowledgment by any researcher developing a chemotherapeutic drug.  
The fact that paclitaxel began to break up the MCS before causing apoptosis in all the cells 
further suggests that the chemotherapeutic must work its way through the many layers of a tumor 
before it can inhibit the cancer cells. The differences in 2D and 3D model drug response in LCC 
 
 
 
 
conditions leads to the assumption that a similar pattern will occur in AIC conditions. AIC 
culture also has other characteristics to consider. TEER significantly increases across a 
monolayer of the Calu-3 cell line. The resistance is due to a tightly packed structure that prevents 
leakage of fluids in the lung.  This resistance remains the same with the application of direct 
PTX-loaded nanoparticle delivery to this cell monolayer, implying that the nanoparticles can be 
safely delivered to lung tissue without comprising the tissue and causing it to become leaky with 
fluid or permeable to other harmful particles. Lastly, the 3D AIC model proves to represent more 
characteristics similar to in vivo (such as protective musical layers) when analyzing cellular 
response to direct pulmonary delivery of PTX-loaded lipospheres.  
 
6. Future Work 
 After the successful development of a dependable 3D model to specifically mimic a lung 
tumor that is exposed directly to air, the possibility of direct pulmonary delivery arises. 
Experimentation with this in vitro model using aerosolized lipospheres loaded with paclitaxel is 
likely to contribute valuable information concerning plausible direct pulmonary delivery. MCS 
grown in AIC conditions will be exposed to the DPPC:PTX particles in varying concentrations 
with an insufflator to model a direct pulmonary application of the anti-cancer drug. Cell viability 
curves and IC50 values will also be measured and analyzed similar to the analysis done on the 
MCS grown in LCC conditions. The differences in AIC and LCC responses will provide 
information on the effects of two different growth conditions as well as the effects which the two 
different methods of drug delivery have on the drug response. In addition, a distinction will be 
made between drug response in the 2D compared with the 3D model in this more unique 
culturing method that is specific to recreating a lung tumor and tumor microenvironment. Much 
is still to be learned from this new lung tumor model. 
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